Fundraising Fox

Acacia Pharma

Indianapolis, US · 2 known investors

Find your way into Acacia Pharma

Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.

BiotechHealthtechMedical Devices

Investors · 2

F-Prime CapitalCambridge · $3M – $10M
Gilde Healthcarereported · 2 sourcesUtrecht · $1.1M – $55M

In the news

Acacia Pharma raises €25M to launch BARHEMSYS® and BYFAVO™ in the US - Gilde Healthcaregildehealthcare.com · Aug 2020Acacia Pharma Raises £15 Million ($23.5 Million) to Advance Clinical Development of Lead Products for Supportive Care | Fierce Biotechfiercebiotech.com · Sep 2013Acacia Pharma raises £6.2 million in Series A - Growth Businessgrowthbusiness.co.uk · Apr 2011Acacia Pharma Closes $10 Million Investment Round - Gilde Healthcaregildehealthcare.com · Mar 2011Acacia Pharma (EURONEXT: ACPH) raises EUR 27 million for US launch | News | Gilde Healthcaregildehealthcare.com

Frequently asked questions

What does Acacia Pharma do?
Eagle Pharmaceuticals develops and commercializes specialty pharmaceutical products for acute care and oncology, including injectable medications for procedural sedation, chemotherapy, lymphomas, and malignant hyperthermia management.
Who are Acacia Pharma's investors?
Acacia Pharma's investors include F-Prime Capital, Gilde Healthcare.
Where is Acacia Pharma headquartered?
Acacia Pharma is headquartered in Indianapolis, US.